Check out our most popular compounded medications! Get Started
Description: Dehydroepiandrosterone (DHEA) 5 mg Slow Release (MEM4) Oral Capsules are a specialized formulation designed to provide a controlled release of DHEA, an endogenous steroid hormone. These capsules are compounded using Methocel E4M, a hydrophilic matrix that forms a gel barrier upon contact with gastrointestinal fluids. This matrix controls the rate of DHEA release into the bloodstream, ensuring a steady and prolonged therapeutic effect. The slow release mechanism is particularly beneficial in maintaining consistent hormone levels, which can be crucial in the management of conditions such as adrenal insufficiency, depression, and osteoporosis, where DHEA levels are found to be suboptimal. By reducing the dosing frequency, this formulation also enhances patient compliance, a key factor in the successful management of chronic conditions.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Dehydroepiandrosterone (DHEA) is an endogenous steroid hormone that serves as a precursor to androgens and estrogens, which are vital for a wide array of physiological functions. Our formulation of DHEA 5 mg Slow Release (MEM4) Oral Capsules is meticulously crafted to ensure a steady release of DHEA into the bloodstream, utilizing Methocel E4M, a high-viscosity grade of hydroxypropyl methylcellulose. This controlled-release polymer is specifically chosen for its ability to form a gel matrix when exposed to gastrointestinal fluids, thereby slowing the release rate of the active ingredient.
The slow-release formulation is designed to mimic the body's natural rhythm of DHEA production, which typically decreases with age. By providing a sustained release of DHEA, our capsules aim to restore physiological levels of the hormone over a prolonged period, potentially benefiting patients with conditions associated with low DHEA levels. These conditions may include adrenal insufficiency, where the adrenal glands do not produce adequate amounts of hormones, and certain types of depression, where DHEA supplementation has been shown to have antidepressant effects.
Moreover, the slow-release mechanism of our DHEA capsules can lead to improved patient compliance by reducing the dosing frequency compared to immediate-release formulations. This is particularly beneficial for chronic conditions that require long-term, consistent hormone levels. It is important to note that while DHEA supplementation may offer therapeutic benefits, it should be used under the supervision of a healthcare provider, as hormone therapy can have significant effects on the body and may interact with other medications.
For prescribers considering this formulation, it is essential to evaluate the patient's hormone levels and overall health status to determine the appropriateness of DHEA therapy. Regular monitoring of hormone levels and clinical response should guide any adjustments in dosing. Patients should be informed about the potential benefits and risks associated with DHEA supplementation, including the possibility of side effects such as acne, hair loss, and hormonal imbalances.
If you have any questions or require further information about our DHEA 5 mg Slow Release (MEM4) Oral Capsules, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is dedicated to providing comprehensive support and guidance to ensure the safe and appropriate use of our formulations.
Dehydroepiandrosterone (DHEA) is an endogenous steroid hormone that serves as a precursor to androgens and estrogens. It is involved in a wide array of physiological processes, including immune function, brain function, bone metabolism, and the regulation of body composition. DHEA supplementation is used for conditions such as adrenal insufficiency, depression, induction of labor, and systemic lupus erythematosus, among others. However, due to its hormonal nature, DHEA can interact with various medications and substances, which may alter its effectiveness or increase the risk of adverse effects.
When considering DHEA in a slow-release formulation, it is important to be aware of potential drug interactions. DHEA may interact with anticoagulants or antiplatelet agents, such as warfarin or aspirin, potentially increasing the risk of bleeding. Patients taking these medications should be monitored closely for signs of bleeding and coagulation parameters should be checked regularly. Additionally, DHEA may influence insulin sensitivity and glucose metabolism, which necessitates caution in patients using antidiabetic drugs, as there may be a need for dosage adjustments to maintain glycemic control.
Hormone-sensitive conditions, such as breast cancer, uterine cancer, ovarian cancer, endometriosis, or uterine fibroids, may be exacerbated by DHEA supplementation due to its conversion to estrogen and testosterone. Patients with these conditions should avoid using DHEA unless specifically recommended by a healthcare provider. Furthermore, DHEA may interact with other hormones or hormone therapies, including thyroid medications, and may necessitate dose adjustments or close monitoring of thyroid function tests.
Concomitant use of DHEA with other supplements or herbs that have hormonal activity, such as black cohosh or soy products, may result in additive effects and increase the risk of side effects. It is also advisable to exercise caution when combining DHEA with CNS-active agents, including antidepressants, anxiolytics, or sedatives, as DHEA may influence mood and behavior.
Patients with liver disease should use DHEA with caution, as it is metabolized in the liver and may affect liver enzyme levels. Regular liver function tests may be warranted in these patients. Additionally, DHEA may alter cholesterol levels and should be used cautiously in patients with lipid disorders or those taking lipid-lowering medications, such as statins.
Given the complexity of these interactions, it is crucial for prescribers to thoroughly evaluate the patient's current medication regimen and health status before initiating DHEA therapy. Patients should be advised to inform their healthcare provider of all medications, supplements, and herbs they are taking. Regular follow-up and monitoring for signs of interaction or adverse effects are recommended. If you have any questions or require further information regarding this formulation and its potential interactions, please reach out to us at Bayview Pharmacy.
Dehydroepiandrosterone, commonly known as DHEA, is a hormone produced by the adrenal glands, which acts as a precursor to male and female sex hormones. The 5 mg slow-release oral capsules of DHEA are specifically designed to mimic the body's natural rhythm of hormone release. This is achieved through the incorporation of Methocel E4M, a hydrophilic methylcellulose polymer that swells and forms a gel when it comes into contact with gastric fluids. This gel matrix creates a barrier through which the DHEA is slowly released into the bloodstream.
The slow-release mechanism provided by Methocel E4M is particularly beneficial for maintaining stable hormone levels throughout the day, which can be crucial for patients with adrenal insufficiency or those who are undergoing various treatments that necessitate the supplementation of DHEA. By ensuring a steady release, the formulation minimizes the peaks and troughs in hormone levels that can be associated with standard immediate-release preparations, thereby reducing the potential for side effects and improving overall treatment efficacy.
In terms of treating disease states, DHEA supplementation has been explored for a variety of conditions, including adrenal insufficiency, depression, osteoporosis, and systemic lupus erythematosus, among others. While the efficacy of DHEA in these conditions is still under investigation, the slow-release formulation may offer advantages in terms of consistent hormone exposure and reduced dosing frequency, which can lead to better patient adherence to the medication regimen. It is important to note that the use of DHEA should be closely monitored by a healthcare provider, as hormone therapy can have significant effects on the body.
For patients and prescribers considering the use of Dehydroepiandrosterone 5 mg Slow Release (MEM4) Oral Capsules, it is essential to understand the pharmacokinetic profile of the formulation. The slow-release capsules are intended to be taken once daily, or as directed by a healthcare professional, to maintain optimal therapeutic levels of DHEA. The Methocel E4M polymer ensures that the release of DHEA is not only gradual but also predictable, which is critical for managing conditions that require precise hormone regulation.
As compounding pharmacists at Bayview Pharmacy, we are committed to providing high-quality, customized medication solutions to meet the unique needs of each patient. If you have any questions about this formulation or how it can be integrated into a treatment plan, please do not hesitate to reach out to us. Our team is here to support both patients and prescribers with the information and guidance necessary to make informed decisions about the use of compounded medications.
Dehydroepiandrosterone 5 mg Slow Release (MEM4) Oral Capsules is a medication formulated with Methocel E4M, which is designed to release the hormone DHEA gradually over a prolonged period. This controlled-release delivery system ensures sustained therapeutic effects and promotes better patient compliance.
Methocel E4M is a type of controlled-release polymer used in pharmaceuticals as a matrix to encapsulate the active ingredient. In DHEA 5 mg Slow Release Capsules, it functions to slowly release DHEA into the system, thereby maintaining consistent blood levels over time.
A patient may be prescribed DHEA 5 mg Slow Release Capsules if they have a deficiency of this hormone or require supplementation for conditions under medical supervision. Since DHEA levels decline with age, supplementation could be considered for various age-related health conditions.
The dosing frequency of DHEA 5 mg Slow Release Capsules will be determined by the prescribing healthcare provider based on individual patient needs. Due to its sustained release formulation, it may be taken less frequently than immediate-release counterparts.
Whether DHEA 5 mg Slow Release Capsules can be taken with other medications should be determined by your healthcare provider. They can assess potential interactions and adjust your medication regimen accordingly.
DHEA 5 mg Slow Release Capsules should be stored at room temperature, away from moisture and heat. Keep the bottle tightly closed when not in use, and keep out of reach of children.
Side effects of DHEA supplementation can include acne, hair loss, stomach upset, high blood pressure, and changes in menstrual cycle in women. Prolonged use of DHEA should be monitored by a healthcare provider as it can have significant effects.
The onset of action will vary among individuals, but the slow release formulation is designed to provide a gradual increase in DHEA levels over time. It may take a few days to several weeks to notice the benefits of the medication.
DHEA 5 mg Slow Release Capsules should not be opened, split, or crushed, as this can interfere with the controlled-release mechanism designed to release the hormone slowly over time. They should be swallowed whole with water.
The safety of using DHEA 5 mg Slow Release Capsules during pregnancy or while breastfeeding has not been established. Always consult a healthcare provider before taking any medication in these situations.
If you miss a dose of DHEA 5 mg Slow Release Capsules, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at once without consulting your healthcare provider.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
